# FDA 483 - Kwabena Ntoso M.D - October 11, 2023

Source: https://www.keypedia.com/records/483/kwabena-ntoso-md/caf3e44f-4d68-4e97-9b71-f91ae95c67cb

> FDA 483 for Kwabena Ntoso M.D on October 11, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kwabena Ntoso M.D
- Inspection Date: 2023-10-11
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of Kwabena Ntoso M.D, a clinical investigator site in Philadelphia, PA, revealed significant deficiencies in record-keeping practices. The site failed to maintain adequate study source records for a majority of screened subjects and did not retain signed informed consent forms. Additionally, required investigation records were not retained for the specified two-year period.

## Related Officers

- [investigator](https://www.keypedia.com/people/anastasia-i-onuorah/d081d002-e4a4-4001-ba06-b71ff9fbf9f7)

Company: https://www.keypedia.com/companies/kwabena-ntoso-md/7c4b9a36-aa26-4061-b455-0cae6be18d04

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8